Web monitoring for capturing real-world feedback on drugs
First live demo of PLG’s powerful new AI-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
ProductLife Group (PLG) is to host a webinar on the growing importance of web monitoring as a source of timely, real-world product feedback for drugs companies. The short session, which will take place on 26 April at 2:00PM CET, will include the first live demo of PLG’s powerful new artificial-intelligence-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
During the webinar, AI experts will explore the unique scope of web forums and public social media channels for monitoring consumers’ real-world experience of life sciences products, and to build up an early picture of potential adverse effects. Although the life sciences industry has long understood the potential for timely insight at large scale offered by web and social media listening, the issue until now has been how to monitor these digital channels in an efficient and reliable way to distil the findings that matter - and to do this in a way that respects people’s privacy
.The session will include a first, exclusive look at PLG inVolv via a live demo of the new artificial-intelligence (AI)-based solution, which meets these important criteria. Crucially, it uses machine learning to adapt to the kinds of findings life sciences organisations are most interested in, so that professionals do not waste time looking at content that isn’t of value.
PLG inVolv, which is provided via a software-as-a-service (SaaS) delivery model and is designed to complement rather than replace existing product vigilance and clinical safety systems, is the result of an exclusive partnership with Volv, a specialist in AI-based social listening technology for life sciences.
The webinar, which will run for half an hour, is open to a limited number of participants to allow enough time for a Q&A session following the demonstration. Commenting on the event, Adam Sherlock, CEO of ProductLife Group, said: “Social listening in life sciences, especially in the context of safety and pharmacovigilance, is a hugely hot topic at the moment. Companies are under increasing pressure to proactively track the impact of their products in the market, and what better way than with the help of machine learning and targeted web and social listening? This webinar is very timely, and we expect the session to be over-subscribed.”
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance